Liquid Medical Marijuana Shows Promise Against Severe Epilepsy
MONDAY, April 13, 2015 (HealthDay News) -- A liquid form of medical marijuana may help people with severe epilepsy that does not respond to other treatments, according to a new report.
The study included 213 child and adult patients with 12 different types of severe epilepsy. Some of them had Dravet syndrome and Lennox-Gastaut syndrome, which are types of epilepsy that can cause intellectual disability and lifelong seizures.
The patients took a liquid form of medical marijuana, called cannabidiol, daily for 12 weeks.
Among the 137 people who completed the study, the number of seizures fell by an average of 54 percent, according to a team led by Dr. Orrin Devinsky, of New York University Langone Comprehensive Epilepsy Center in New York City.
Among the 23 patients with Dravet syndrome who completed the study, the number of convulsive seizures fell by 53 percent, the investigators found. The 11 patients with Lennox-Gastaut syndrome who finished the study also had a 55 percent decline in the number of attacks called "atonic" seizures, which cause a sudden loss of muscle tone.WebMD News from HealthDay Copyright © 2013-2018 HealthDay. All rights reserved.
- Liquid Medical Marijuana Shows Promise Against Severe Epilepsywww.webmd.com
- Access to Marijuana Shows Promise in Combating America’s Opioid Crisisblog.norml.orgAugust 31, 2018
- 10 YEARS and $8.7m of Research Shows "Promise" for Medical Marijuanastuffstonerslike.comFebruary 25, 2010
- Tilray® 2:100 Product Shows Promise in Canada’s First Pediatric Study of Mixed THC/CBD Medical Cannabis Oil for Children with Drug-Resistant Epilepsywww.tilray.com